AVEO Pharmaceuticals, Inc.
Charter Amendment in a 10-Q on 08/08/2019   Download
SEC Document
SEC Filing

 

      

 

 

 

 

 

 

 

 

 

State of Delaware

Secretary of State

Division of Corporations

Delivered 08:33 AM 06/26/2017

FILED 08:33 AM 06/26/2017

SRV 20174935494 – File Number 3444819

CERTIFICATE OF AMENDMENT

OF

RESTATED CERTIFICATE OF INCORPORATION

OF

AVEO PHARMACEUTICALS, INC.

AVEO Pharmaceuticals, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “General Corporation Law”), does hereby certify as follows:

 

1.

The name of the Corporation is AVEO Pharmaceuticals, Inc.

 

2.

Article FOURTH of the Restated Certificate of Incorporation of the Corporation, is hereby amended by replacing the first paragraph thereof with the following:

“FOURTH: The total number of shares of all classes of stock which the Corporation shall have authority to issue is 255,000,000 shares, consisting of (i) 250,000,000 shares of Common Stock, $0.001 par value per share (“Common Stock”) and (ii) 5,000,000 shares of Preferred Stock, $0.001 par value per share (“Preferred Stock”).”

 

3.

This Certificate of Amendment has been duly adopted by the Board of Directors and stockholders of the Corporation in accordance with Section 242 of the General Corporation Law.

* * *

 


 

IN WITNESS WHEREOF, the Corporation has caused its duly authorized officer to execute this Certificate of Amendment on this 26th day of June, 2017.

 

 

 

 

AVEO PHARMACEUTICALS, INC.

 

 

By:

 

/s/ Michael Bailey

Name:

Title

 

Michael Bailey

President and Chief Executive Officer